ArticleResearch and practice in thrombosis and haemostasis2026

Etranacogene dezaparvovec in people with hemophilia B and without adeno-associated virus serotype 5 neutralizing antibodies: a 4-year subgroup analysis of the Health Outcomes with Padua Gene; Evaluation in Hemophilia B (HOPE-B) trial.

Priyanka Raheja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.